The table below is a review of notable updates that occurred in January 2025 for investigational products in development.

On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...

Sweaty feet can be caused by several factors, from lifestyle and shoewear to medical conditions. Here are the potential causes and how to stop excessive sweating.

Purpose: The pharmacology, pharmacokinetics, clinical efficacy, and safety of rasagiline are reviewed. Summary: Rasagiline is a novel, investigational propargylamine that irreversibly and ...

In a clinical trial, patients treated with a kidney cancer vaccine remained cancer-free after a median of nearly three years.